• Wondering if H.B. Fuller at around US$63.13 is offering real value or just a steady story in the chemicals space? This article will help you weigh what that price might mean for you.
• The stock has returned 1.1% over the last week, 18.6% over 30 days, 4.6% year to date, and 16.6% over the past year, with much flatter results over 3 years and 5 years.
• Recent attention around H.B. Fuller has focused on how the business is positioned within the wider materials sector and how investors are thinking about quality and stability in this area. This backdrop helps frame the recent share price moves and why valuation is back in focus for many holders.
• Right now, the company scores 2 out of 6 on Simply Wall St's valuation checks. The next sections will compare different valuation approaches and will finish with a way to assess value that goes beyond a single score.

H.B. Fuller scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: H.B. Fuller Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company could be worth by projecting its future cash flows and then discounting those back to today using a required rate of return. It is essentially asking what those future dollars are worth in today’s terms.

For H.B. Fuller, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is about $177.35 million. Analysts provide explicit free cash flow estimates for the first few years, and Simply Wall St then extrapolates cash flows further out, including a projection of $210.22 million in 2035, with intermediate years such as $184.00 million in 2028 and $204.08 million in 2034, all discounted back to today.

When all those discounted cash flows are added together, the estimated intrinsic value comes out at about $57.20 per share. Compared with a recent share price around $63.13, the model suggests the stock is about 10.4% overvalued on this basis, so the current price sits a bit above the DCF estimate.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests H.B. Fuller may be overvalued by 10.4%. Discover 54 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: H.B. Fuller Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about value because it links what you pay today to the earnings the business is already generating. A higher or lower P/E often reflects what the market is pricing in for future growth, as well as how much risk investors feel they are taking on.

H.B. Fuller is trading on a P/E of 21.53x. That sits below the Chemicals industry average of 29.75x and the peer group average of 31.20x, so the market is currently assigning it a lower earnings multiple than many sector peers. On the surface, that can suggest a more cautious view from investors, or simply different expectations for growth and risk.

Simply Wall St’s Fair Ratio framework goes a step further. It estimates what a “normal” P/E should be for H.B. Fuller, based on factors such as its earnings growth profile, profit margins, industry, market cap and specific risk characteristics. For H.B. Fuller, this Fair Ratio is 18.91x, which is below the current 21.53x P/E. On this basis, the shares screen as somewhat expensive relative to what the Fair Ratio model suggests.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 17 top founder-led companies.

Upgrade Your Decision Making: Choose your H.B. Fuller Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so meet Narratives, a simple tool on Simply Wall St’s Community page that lets you set out your own story for H.B. Fuller, link that story to specific forecasts for revenue, earnings and margins, convert those forecasts into a Fair Value, compare that to the current share price to help you decide whether the stock looks expensive or cheap, and then see that view update automatically as fresh news or earnings arrive. This is why one investor might build a more optimistic H.B. Fuller Narrative closer to the US$84.00 analyst target, while another takes a more cautious view nearer US$58.00, both using the same company but very different assumptions about what the future may look like.

Do you think there's more to the story for H.B. Fuller? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.